216 related articles for article (PubMed ID: 37710353)
1. Identification of molecular signatures and pathways involved in Rett syndrome using a multi-omics approach.
Pascual-Alonso A; Xiol C; Smirnov D; Kopajtich R; Prokisch H; Armstrong J
Hum Genomics; 2023 Sep; 17(1):85. PubMed ID: 37710353
[TBL] [Abstract][Full Text] [Related]
2. Rett syndrome: the complex nature of a monogenic disease.
Renieri A; Meloni I; Longo I; Ariani F; Mari F; Pescucci C; Cambi F
J Mol Med (Berl); 2003 Jun; 81(6):346-54. PubMed ID: 12750821
[TBL] [Abstract][Full Text] [Related]
3. RNA sequencing and proteomics approaches reveal novel deficits in the cortex of
Pacheco NL; Heaven MR; Holt LM; Crossman DK; Boggio KJ; Shaffer SA; Flint DL; Olsen ML
Mol Autism; 2017; 8():56. PubMed ID: 29090078
[TBL] [Abstract][Full Text] [Related]
4. A proteomic approach to investigate the role of the MECP2 gene mutation in Rett syndrome redox regulatory pathways.
Pasqui A; Cicaloni V; Tinti L; Guiotto A; Tinti C; Mori A; Bruttini M; Hayek J; Pecorelli A; Salvini L; Valacchi G
Arch Biochem Biophys; 2024 Feb; 752():109860. PubMed ID: 38110111
[TBL] [Abstract][Full Text] [Related]
5. Multi-omics in MECP2 duplication syndrome patients and carriers.
Pascual-Alonso A; Xiol C; Smirnov D; Kopajtich R; Prokisch H; Armstrong J
Eur J Neurosci; 2024 May; ():. PubMed ID: 38746988
[TBL] [Abstract][Full Text] [Related]
6. MECP2 mutations and clinical correlations in Greek children with Rett syndrome and associated neurodevelopmental disorders.
Psoni S; Sofocleous C; Traeger-Synodinos J; Kitsiou-Tzeli S; Kanavakis E; Fryssira-Kanioura H
Brain Dev; 2012 Jun; 34(6):487-95. PubMed ID: 21982064
[TBL] [Abstract][Full Text] [Related]
7. Quantitative proteomic analysis of Rett iPSC-derived neuronal progenitors.
Varderidou-Minasian S; Hinz L; Hagemans D; Posthuma D; Altelaar M; Heine VM
Mol Autism; 2020 May; 11(1):38. PubMed ID: 32460858
[TBL] [Abstract][Full Text] [Related]
8. Rett-causing mutations reveal two domains critical for MeCP2 function and for toxicity in MECP2 duplication syndrome mice.
Heckman LD; Chahrour MH; Zoghbi HY
Elife; 2014 Jun; 3():. PubMed ID: 24970834
[TBL] [Abstract][Full Text] [Related]
9. MECP2 Duplication Syndrome: Evidence of Enhanced Oxidative Stress. A Comparison with Rett Syndrome.
Signorini C; De Felice C; Leoncini S; Møller RS; Zollo G; Buoni S; Cortelazzo A; Guerranti R; Durand T; Ciccoli L; D'Esposito M; Ravn K; Hayek J
PLoS One; 2016; 11(3):e0150101. PubMed ID: 26930212
[TBL] [Abstract][Full Text] [Related]
10. Proteomic analysis of the Rett syndrome experimental model mecp2
Cortelazzo A; Pietri T; De Felice C; Leoncini S; Guerranti R; Signorini C; Timperio AM; Zolla L; Ciccoli L; Hayek J
J Proteomics; 2017 Feb; 154():128-133. PubMed ID: 28062374
[TBL] [Abstract][Full Text] [Related]
11. Identification and characterization of conserved noncoding
Shao Y; Bajikar SS; Tirumala HP; Gutierrez MC; Wythe JD; Zoghbi HY
Genes Dev; 2021 Apr; 35(7-8):489-494. PubMed ID: 33737384
[TBL] [Abstract][Full Text] [Related]
12. Rett Syndrome, a Neurodevelopmental Disorder, Whole-Transcriptome, and Mitochondrial Genome Multiomics Analyses Identify Novel Variations and Disease Pathways.
Aldosary M; Al-Bakheet A; Al-Dhalaan H; Almass R; Alsagob M; Al-Younes B; AlQuait L; Mustafa OM; Bulbul M; Rahbeeni Z; Alfadhel M; Chedrawi A; Al-Hassnan Z; AlDosari M; Al-Zaidan H; Al-Muhaizea MA; AlSayed MD; Salih MA; AlShammari M; Faiyaz-Ul-Haque M; Chishti MA; Al-Harazi O; Al-Odaib A; Kaya N; Colak D
OMICS; 2020 Mar; 24(3):160-171. PubMed ID: 32105570
[TBL] [Abstract][Full Text] [Related]
13. Two new Rett syndrome families and review of the literature: expanding the knowledge of MECP2 frameshift mutations.
Ravn K; Roende G; Duno M; Fuglsang K; Eiklid KL; Tümer Z; Nielsen JB; Skjeldal OH
Orphanet J Rare Dis; 2011 Aug; 6():58. PubMed ID: 21878110
[TBL] [Abstract][Full Text] [Related]
14. Exploration of group II metabotropic glutamate receptor modulation in mouse models of Rett syndrome and MECP2 Duplication syndrome.
Vermudez SAD; Buch A; Weiss K; Gogliotti RG; Niswender CM
Neuropharmacology; 2022 May; 209():109022. PubMed ID: 35248529
[TBL] [Abstract][Full Text] [Related]
15. Sensory experiences questionnaire unravels differences in sensory profiles between MECP2-related disorders.
Suter B; Pehlivan D; Ak M; Harris HK; Lyons-Warren AM
Autism Res; 2024 Apr; 17(4):775-784. PubMed ID: 38433353
[TBL] [Abstract][Full Text] [Related]
16. Exploring the possible link between MeCP2 and oxidative stress in Rett syndrome.
Filosa S; Pecorelli A; D'Esposito M; Valacchi G; Hajek J
Free Radic Biol Med; 2015 Nov; 88(Pt A):81-90. PubMed ID: 25960047
[TBL] [Abstract][Full Text] [Related]
17. Rett Syndrome and
Collins BE; Neul JL
Neuropsychiatr Dis Treat; 2022; 18():2813-2835. PubMed ID: 36471747
[TBL] [Abstract][Full Text] [Related]
18. Rett syndrome: methyl-CpG-binding protein 2 mutations and phenotype-genotype correlations.
Amir RE; Zoghbi HY
Am J Med Genet; 2000; 97(2):147-52. PubMed ID: 11180222
[TBL] [Abstract][Full Text] [Related]
19. MeCP2 mutations in children with and without the phenotype of Rett syndrome.
Hoffbuhr K; Devaney JM; LaFleur B; Sirianni N; Scacheri C; Giron J; Schuette J; Innis J; Marino M; Philippart M; Narayanan V; Umansky R; Kronn D; Hoffman EP; Naidu S
Neurology; 2001 Jun; 56(11):1486-95. PubMed ID: 11402105
[TBL] [Abstract][Full Text] [Related]
20. Isolation of MECP2-null Rett Syndrome patient hiPS cells and isogenic controls through X-chromosome inactivation.
Cheung AY; Horvath LM; Grafodatskaya D; Pasceri P; Weksberg R; Hotta A; Carrel L; Ellis J
Hum Mol Genet; 2011 Jun; 20(11):2103-15. PubMed ID: 21372149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
